Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Harvard Business School
Express Scripts
Medtronic
Boehringer Ingelheim

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Dr Reddys Labs Ltd Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS LTD, and what generic and branded alternatives to DR REDDYS LABS LTD drugs are available?

DR REDDYS LABS LTD has one hundred and twenty-nine approved drugs.

There are eighteen tentative approvals on DR REDDYS LABS LTD drugs.

Summary for Dr Reddys Labs Ltd
US Patents:0
Tradenames:101
Ingredients:96
NDAs:129

Drugs and US Patents for Dr Reddys Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 076534-003 Oct 24, 2011 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Dr Reddys Labs Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 201576-002 Jun 6, 2012 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Dr Reddys Labs Ltd RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 077328-004 Nov 30, 2009 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Dr Reddys Labs Ltd ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 090609-001 Feb 23, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for DR REDDYS LABS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKesson
Dow
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.